International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity.
Capucine Picard, H Bobby Gaspar, Waleed Al-Herz...
https://pubmed.ncbi.nlm.nih.gov/29226302/Actively Recruiting
Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2026-10-26
3000
Participants Needed
3
Research Sites
N/A
Total Duration
This research aims to better understand primary immunodeficiency disorders PIDs, which are conditions that weaken the immune system and increase the risk of infections. These disorders are often inherited, so identifying the causes is important to guide treatment decisions. The study focuses on people with PIDs and their biological relatives to explore the genetic and molecular factors involved. Participants provide various biological samples from home or local settings, including blood drawn from a vein or fingerheel prick, saliva, urine, stool, and swabs from the nose or cheek. If participants have a baby during the study, cord blood samples from the newborn may also be collected. Samples from any medical procedures performed during the study might be used as well. The study involves no in-person visits to the research center. Participants will undergo remote screening through medical history interviews, and researchers may communicate with their healthcare providers with permission. Genetic and molecular testing will be performed on the collected samples to identify immune system abnormalities and genetic variants linked to PIDs. Results that impact health and care will be shared with participants and their doctors. Participation can last until the study ends in 2038, with ongoing sample collection and analysis.
CONDITIONS
Send-In Sample Collection to Achieve Genetic and Immunologic Characterization of Primary Immunodeficiencies
P
Pooi M Truong
O
Ottavia M Delmonte, M.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National Institute of Allergy and Infectious Diseases (NIAID)
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility through medical history interviews conducted remotely.
Telephone screening
Duration - Ongoing until study completion
Participants provide biological samples such as blood, saliva, urine, stool, nose or cheek swabs, and cord blood if applicable, typically collected at home or local facilities.
Samples sent by mail or collected locally as needed
Duration - Up to 19 years until study end
Genetic and molecular testing is performed on collected samples to identify immune system abnormalities and genetic variants. Relevant findings are shared with participants and their healthcare providers.
No in-person visits required
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Capucine Picard, H Bobby Gaspar, Waleed Al-Herz...
https://pubmed.ncbi.nlm.nih.gov/29226302/Joshua D Milner, Steven M Holland
https://pubmed.ncbi.nlm.nih.gov/23887241/Ahmed Aziz Bousfiha, Leïla Jeddane, Fatima Ailal...
https://pubmed.ncbi.nlm.nih.gov/23657403/National Institute of Allergy and Infectious Diseases (NIAID)
Lead Sponsor